Old Web
English
Sign In
Acemap
>
authorDetail
>
M. Mertens
M. Mertens
Novartis
Diabetes mellitus
Medicine
Renal function
Calcineurin
Immunology
3
Papers
11
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Improvement in gastrointestinal and health-related quality of life outcomes after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant recipients.
2014
Transplantation Proceedings
Martina Sterneck
Utz Settmacher
T. Ganten
C. Sarrazin
N. Speidel
Dc Broering
Nils Heyne
E.-M. Paulus
M. Mertens
Lutz Fischer
Show All
Source
Cite
Save
Citations (11)
185 THE PROTECT STUDY: EVEROLIMUS MONOTHERAPY vs. CALCINEURIN INHIBITOR-BASED THERAPY RESULTS IN PROGRESSIVE RENAL FUNCTION BENEFIT OVER 35 MONTHS IN LIVER TRANSPLANT RECIPIENTS
2013
Journal of Hepatology
Martina Sterneck
Gernot M. Kaiser
Nicolas Richter
Nils Heyne
F. Rauchfuss
P. Neuhaus
Peter Schemmer
Lutz Fischer
E.-M. Paulus
M. Mertens
Hans J. Schlitt
Show All
Source
Cite
Save
Citations (0)
Critical Relevance of Early Calcineurin‐Inhibitor Exposure for Long‐Term Renal Function After Liver Transplantation: Response to Letter by Rodríguez‐Perálvarez et al.
2013
American Journal of Transplantation
Hans J. Schlitt
M. Mertens
Lutz Fischer
Show All
Source
Cite
Save
Citations (0)
1